期刊文献+

胆结石患者垂体-性腺轴激素变化的研究 被引量:8

The study on pituitary-gonad axis hormones changes in patients with cholelithiasis
下载PDF
导出
摘要 采用放射免疫法测定160例胆结石患者血清FSH、LH和血浆E2、T、P的含量,并与62例年龄相仿的正常健康者对照分析。实验结果表明育龄女性胆囊结石患者E2含量升高(P<0.01),T含量减少(P<0.05);绝经后胆囊结石患者T含量减少.P含量升高(P<0.01);男性胆囊结石患者P含量升高(P<0.05),男性肝胆管结石患者T含量减少(P<0.01);男性和育龄女性胆囊结石患者T和LH含量均减少(P<0.01)。提示胆结石患者存在明显的垂体一性腺轴激素合成或代谢的异常。 Using radioimmunoassay, we determined the concentration of serum follicularstimuating hormone (FSH) luteinizing hormone (LH ), and that of plasma estradio (E2),progesterone (P),testosterone (T) in 160 patients with cholelithiasis and in 62 healthy subjects serving as the contral. The results showed that the level of plasma E2was greatly higher (P <0. 01 ) and the level of plasma T was significantly lower (P< 0.05) in reproductive aged women with gallstones. The postmenopausal women with gallstones has lower plasma T values and much higher plasma P values than the healthy subjects (P<0. 01). The P of the male patients with gallstones were higher as compared with the control group (P< 0. 05). The male patients with hepatic bile duct stones has significantly low T values (P<0.01). Between male and reproductive aged women with gallstones,Tand LH decreased. It is suggested that the synthesis or metablism of pituitary-gonadal axis hormones in patientS with oh lelithia are significantly abnormal.
出处 《肝胆外科杂志》 1994年第1期26-29,共4页 Journal of Hepatobiliary Surgery
关键词 胆结石 垂体 性腺 激素 cholelithiasis pituitary gonads hormones E_2/T
  • 相关文献

同被引文献34

  • 1王成友,余宏铸,张薇薇.性激素类药物诱发胆囊结石的实验研究[J].中国临床药理学与治疗学,1996,1(1):29-30. 被引量:1
  • 2薛涣洲,李干骏.雌性激素与胆结石成因的实验研究[J].中华外科杂志,1989,27(11):686-688. 被引量:6
  • 3刘存钰.胆石症.实用内科学[M].北京:人民卫生出版社,1993.1472.
  • 4薛涣洲.雌性激素与胆汁及血中脂质浓度[J].国外医学:消化系疾病分册,1989,9(3):164-164.
  • 5王海云,邵灵,庄培伦.B型超声诊断胆囊结石262例临床分析[J].交通医学,1997,11(1):107-107. 被引量:1
  • 6Barker SS, Pousom R, Wright NA, et al. Expression of estrogen receptor and estrogen-inducible genes in pancreatic cancer. Br J Surg, 1997,84:1085-1089.
  • 7Horimi T, Takasaki I, Toki A, et al. The beneficial effect of tamoxifen therapy in patients with resceted adenocarcinoma of the pancreas. Hepatogastroenterology, 1996, 43:1225-1229.
  • 8Andren-Sandberg A, Hoem D, Backnam PL. Other risk factor for pancreatic cancer : hormonal aspects. Ann Oncol, 1999,10:131-135.
  • 9Wu CW, Chi CW, Chang TJ, et al. Sex hormone receptors in gastric caner. Cancer, 1990,65:1396.
  • 10Matsui 1, Kojima O, Uehare Y, et al. Characterization of estrogen receptor in human gastric cancer. Cancer,1992,69:305.

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部